Key Developments

A groundbreaking study published in Nature Medicine has demonstrated that AI-based Cognitive Behavioral Therapy (CBT) can outperform human clinical judgment when treating individuals with moderate depression and anxiety. The research has prompted significant commentary from the British Psychological Society’s Cyberpsychology Section, with chair Dr David Harley highlighting both the promise and perils of this technological advancement.

Dr Harley noted that targeted AI training represents “an improvement on more ‘open’ solutions such as generative AI systems” and “is likely to provide stronger safeguards, limiting the likelihood of hallucinations which should reduce the harm that can be done by such systems.”

Industry Context

This development comes at a critical juncture for digital mental health services across Europe, where AI-powered therapeutic interventions are increasingly being integrated into healthcare systems. The timing coincides with the publication of Cyberpsychology.eu’s first 2026 issue, which explores cutting-edge topics including social media behaviour and AI interaction patterns.

The research landscape is evolving rapidly, with upcoming conferences like the BPS Cyberpsychology Conference 2026 (July 6-7 at University of York) featuring keynotes from Prof. Paul Cairns and Prof. Amy Orben addressing these emerging challenges.

Practical Implications

For healthcare providers and technology builders, this research suggests targeted AI systems may offer more reliable therapeutic outcomes than general-purpose AI models. However, the BPS response raises crucial concerns about AI dependency, referencing “recent evidence (Perlis et al, 2026) to suggest that AI dependency may already be an emerging trend with familiar psychological consequences, those same modern dilemmas: depression and anxiety.”

This creates a paradox where AI solutions for mental health may simultaneously contribute to new forms of psychological distress, requiring careful implementation strategies and ongoing monitoring.

Open Questions

Critical questions remain about long-term effects of AI-based therapy, appropriate regulatory frameworks for AI mental health interventions, and how to balance the proven effectiveness of these systems against emerging dependency risks. As European regulators continue developing AI governance frameworks, the intersection of AI capability and psychological wellbeing will require nuanced policy approaches that protect both innovation potential and patient welfare.

Source: British Psychological Society